A paradigm shift in understanding clinically undiagnosible disease and providing precise treatments.
AvestaScan® is a comprehensive Whole Genome (WGS), Whole Exome, Disease-Specific Panel based Sequencing testing solution. Using NGS technology, our portfolio identifies virtually all changes in a patient’s DNA by sequencing both the entire protein coding and non-coding regions of the genome.